Neuroinflamação e taupatia na epilepsia do lobo temporal: associação entre a modulação microglial pela via TREM2/DAP12 e declínio cognitivo
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Temporal lobe epilepsy (TLE) is the most common form of focal epilepsy in adults
and is associated with a high rate of drug resistance. Neuroinflammation is
intrinsically involved in the pathophysiology of the disease, leading to cognitive
outcomes. Recent evidence suggests that microglia and the deposition of
hyperphosphorylated Tau protein (p-Tau) play important roles in the development and
progression of the cognitive impairment associated with TLE; however, the
underlying mechanisms remain poorly understood. The present study investigated
the expression of the microglial markers Iba-1, TREM2, DAP12, and CD68, p-Tau
deposition, microglial morphological alterations, and their associations with cognitive
performance in patients with TLE. Human hippocampal samples were obtained from
patients who underwent selective amygdalohippocampectomy at Hospital Felício
Rocho (Belo Horizonte, Brazil) and Hospital das Clínicas of the Federal University of
Minas Gerais (UFMG) (Belo Horizonte, Brazil), and were compared with hippocampal
samples from control individuals obtained from the Biobank for Aging Studies of the
University of São Paulo (USP) (São Paulo, Brazil). The expression of the
aforementioned proteins was evaluated by immunohistochemistry and
immunofluorescence in the hippocampal subregions CA1, CA2–3, CA4, dentate
gyrus (DG), and subiculum (SUB), and quantified using semi-automated digital
morphometry. The morphology of Iba-1⁺ cells was assessed using Sholl analysis and
the ratio between cell body area and total cell area. Linear regression models
adjusted for clinical variables were also developed to evaluate associations between
the molecular markers and the clinical and cognitive data obtained from preoperative
neuropsychological assessments. The results demonstrated increased expression of
Iba-1 and CD68 across all hippocampal subregions in TLE, accompanied by higher
cell density, reduced branching complexity, and a proportional increase in microglial
cell body size, indicating a more amoeboid and phagocytic microglial phenotype.
TREM2 and DAP12 expression was increased in a region-dependent manner,
particularly in CA1, DG, and SUB. Immunofluorescence confirmed the colocalization
of TREM2 and CD68 with Iba-1, reinforcing the hyperactivated microglial profile in
TLE. p-Tau deposition was increased in all hippocampal subregions and was
positively associated with microglial markers, suggesting an interaction between
tauopathy and neuroinflammation. Furthermore, higher levels of p-Tau, Iba-1,
TREM2, and CD68 were associated with poorer performance across different
cognitive domains in distinct hippocampal subregions, with the most frequent
associations observed with TREM2. Collectively, these findings indicate the presence
of tauopathy in patients with TLE younger than 60 years and suggest that chronic
microglial activation, accompanied by morphological alterations and enhanced
phagocytic activation, responds to this proteinopathy, thereby contributing to
cognitive impairment. These results reinforce the close interaction between
neuroinflammation and neurodegeneration in the pathophysiology of TLE and
highlight the TREM2/DAP12 pathway as a potential target for future mechanistic and
therapeutic investigations.
Description
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Embargado

